Evidence map›Paper›PMID 39931724›Full record

ArticleMedecine tropicale et sante internationale2024

[High prevalence of

Refka Jelassi, Hanen Chelbi, Gabriela Certad, Sadia Benamro Uz-Vanne Ste, Faten Farah, Aida Bouratbine, Karim Aoun

Abstract readEnglish Abstract
In one paragraph

Article in Medecine tropicale et sante internationale, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Refka JelassiUniversité Tunis El Manar, Institut Pasteur de Tunis, Laboratoire de recherche Parasitologie médicale, biotechnologie et biomolécules (LR 20-IPT-06), Tunisie.
Hanen ChelbiUniversité Tunis El Manar, Institut Pasteur de Tunis, Laboratoire de recherche Parasitologie médicale, biotechnologie et biomolécules (LR 20-IPT-06), Tunisie.
Gabriela CertadUniversité de Lille, CNRS, Inserm, Centre hospitalier universitaire (CHU) de Lille, Institut Pasteur de Lille, U1019-UMR9017, Centre d'infection et d'immunité de Lille (CIIL), 59000 Lille, France.
Sadia Benamro Uz-Vanne SteUniversité de Lille, CNRS, Inserm, Centre hospitalier universitaire (CHU) de Lille, Institut Pasteur de Lille, U1019-UMR9017, Centre d'infection et d'immunité de Lille (CIIL), 59000 Lille, France.
Faten FarahUniversité Tunis El Manar, Institut Mohamed Kassab-Ksar Saïd, Hôpital Charles Nicolle, Laboratoire d'anatomie pathologique, Tunisie.
Aida BouratbineUniversité Tunis El Manar, Institut Pasteur de Tunis, Laboratoire de recherche Parasitologie médicale, biotechnologie et biomolécules (LR 20-IPT-06), Tunisie.
Karim AounUniversité Tunis El Manar, Institut Pasteur de Tunis, Laboratoire de recherche Parasitologie médicale, biotechnologie et biomolécules (LR 20-IPT-06), Tunisie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Colorectal cancer (CRC) is a major public health problem, including in Tunisia. It is classified as the second leading cause of cancer-related mortality on a global scale. The carcinogenesis process is multifactorial, mainly involving genetic and environmental factors. Recent studies in various countries suggest that Objective: This study aimed to estimate the prevalence of Materials and methods: Formalin-fixed, paraffin-embedded intestinal biopsies from 39 Tunisian CRC patients were studied. After DNA extraction, Results: The protozoan parasite was detected in five biopsies from CRC patients by at least one PCR (three by the TaqMan technique and three by the HRM technique, including one by both techniques). The overall Conclusion: The high prevalence (13%) of

Indexed as

Colorectal NeoplasmsCryptosporidiosisAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrevalenceTunisiacolorectal cancerCryptosporidiumformalinintestinal biopsiesMaghrebmolecular biologyparaffinPCRTunisia

Identifiers

PMID39931724
PMCPMC11809060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.